E-LIB Suche - Ergebnisse für: Cascavilla, N

1

PB2016: COMPARISON BETWEEN DRD VS KRD AS SALVAGE THERAPY FO..:

Mele, A. ; Prete, E. ; Citiso, S....
HemaSphere. 6 (2022) - p. 1887-1888 , 2022

Link: https://doi.org/10.1097/..

2

P1245: CLINICAL IMPACT OF IMMUNOGLOBULIN HEAVY CHAIN REPERT..:

Alessandria, B. ; Genuardi, E. ; Civita, A. M....
HemaSphere. 6 (2022) - p. 1130-1131 , 2022

Link: https://doi.org/10.1097/..

3

P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE ..:

Mele, G ; Cascavilla, N ; Di Renzo, N...
HemaSphere. 6 (2022) - p. 21-21 , 2022

Link: https://doi.org/10.1097/..

4

PB1984: ELOTUZUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE IN R..:

Bruzzese, A. ; Derudas, D. ; Galli, M....
HemaSphere. 6 (2022) - p. 1856-1857 , 2022

Link: https://doi.org/10.1097/..

5

Daratumumab plus bortezomib or daratumumab plus lenalidomid..:

Mele, G. ; Cascavilla, N. ; Di Renzo, N....
Annals of Hematology. 101 (2022) 8 - p. 1727-1739 , 2022

Link: https://doi.org/10.1007/..

6

P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASON..:

Mele, G ; Cascavilla, N ; Di Renzo, N...
HemaSphere. 6 (2022) - p. 20-21 , 2022

Link: https://doi.org/10.1097/..

7

P564: FINAL RESULTS OF THE QOLESS AZA-AMLE RANDOMIZED TRIAL..:

Oliva, E. N. ; Salutari, P. ; Di Raimondo, F....
HemaSphere. 6 (2022) - p. 463-464 , 2022

Link: https://doi.org/10.1097/..

8

P1084: CHECK-POINT INHIBITORS IN PATIENTS WITH RELAPSE/REFR..:

Gaudio, F. ; Loseto, G. ; Bozzoli, V....
HemaSphere. 6 (2022) - p. 974-975 , 2022

Link: https://doi.org/10.1097/..

9

PIXANTRONE (PIX) IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CEL..:

Greco, A ; Tonialini, L ; Scalzulli, P. R...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

10

BRENTUXIMAB VEDOTIN PRIOR TO ALLOGENEIC STEM CELL TRANSPLAN..:

Gaudio, F. ; Mazza, P. ; Mele, A....
Hematological Oncology. 37 (2019) S2 - p. 494-494 , 2019

Link: https://doi.org/10.1002/..

11

SP232PLASMIC SCORE FOR A QUICK ASSESSMENT OF ADAMTS13 ACTIV..:

Tiscia, G ; Cappucci, F ; Scalzulli, P...
Nephrology Dialysis Transplantation. 33 (2018) suppl_1 - p. i421-i422 , 2018

Link: https://doi.org/10.1093/..

12

LONG TERM RESULTS OF THE FOLL05 RANDOMIZED STUDY COMPARING ..:

Luminari, S. ; Tarantino, V. ; Anastasia, A....
Hematological Oncology. 35 (2017) S2 - p. 34-34 , 2017

Link: https://doi.org/10.1002/..

13

POD24 AND CR30 ARE PROMISING SURROGATE ENDPOINTS FOR ASSESS..:

Luminari, S. ; Marcheselli, L. ; Manni, M....
Hematological Oncology. 35 (2017) S2 - p. 228-229 , 2017

Link: https://doi.org/10.1002/..

14

Continuous treatment improves survival of newly diagnosed m..:

Cerrato, C. ; Gay, F. ; Petrucci, M.T....
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. e54 , 2015

Link: https://doi.org/10.1016/..

15

Real world" outcome of lenalidomide plus dexamethasone in t..:

Mele, G. ; Melpignano, A. ; Quarta, G....
Leukemia Research. 39 (2015) 3 - p. 279-283 , 2015

Link: https://doi.org/10.1016/..